1. Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation
- Author
-
Karuna E W Vendrik, Elisabeth M Terveer, Ed J Kuijper, Sam Nooij, Eline Boeije-Koppenol, Ingrid M J G Sanders, Emilie van Lingen, Hein W Verspaget, Eric K L Berssenbrugge, Josbert J Keller, Joffrey van Prehn, Eduard J. Kuijper, Josbert J. Keller, Elisabeth M. Terveer, Karuna E.W. Vendrik, Eric K.L. Berssenbrugge, Hein W. Verspaget, Martijn P. Bauer, Abraham Goorhuis, Els van Nood, Chris J.J. Mulder, Rogier Ooijevaar, Yvette van Beurden, Christina M.J.E. Vandenbroucke-Grauls, Internal Medicine, and Medical Microbiology & Infectious Diseases
- Subjects
0301 basic medicine ,Adult ,Male ,030106 microbiology ,Faecal microbiota transplantation ,Microbiology ,law.invention ,03 medical and health sciences ,Feces ,Young Adult ,0302 clinical medicine ,law ,Drug Resistance, Multiple, Bacterial ,Quarantine ,Escherichia coli ,Medicine ,Humans ,030212 general & internal medicine ,Escherichia coli Infections ,Netherlands ,Retrospective Studies ,Transmission (medicine) ,business.industry ,Microbiota ,Retrospective cohort study ,Fecal Microbiota Transplantation ,Middle Aged ,Transplantation ,Multiple drug resistance ,Infectious Diseases ,Multilocus sequence typing ,Female ,business ,Multilocus Sequence Typing - Abstract
Background On June 13, 2019, the US Food and Drug Administration issued a warning after transfer of faeces containing an extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli by faecal microbiota transplantation led to bacteraemia in two immunocompromised patients. Consequently, we evaluated the effectiveness of the faeces donor-screening protocol of the Netherlands Donor Faeces Bank, which consists of screening of donors for multidrug-resistant organisms every 3 months, combined with additional screening on indication (eg, after travelling abroad) and application of a quarantine period for all faecal suspensions delivered within those 3 months.Methods We did a retrospective cohort study of data collected between Jan 1, 2015, and Oct 14, 2019, on the multidrug-resistant organism testing results of donor faeces. Additionally, we tested previously quarantined faecal suspensions approved for faecal microbiota transplantation between Dec 12, 2016, and May 1, 2019, for the presence of multidrug-resistant organisms using both aselective and selective broth enrichment media. Whole-genome sequencing with core-genome multilocus sequence typing (cgMLST) was done on all multidrug-resistant isolates.Findings Among initial screenings, six (9%) of 66 tested individuals were positive for multidrug-resistant organisms and 11 (17%) of 66 tested individuals were positive for multidrug-resistant organisms at any timepoint. Multidrug-resistant organisms were detected in four (25%) of 16 active donors, who had a median donation duration of 268 days (IQR 92 to 366). Among all screening results, 14 (74%) of 19 detected multidrug-resistant organisms were ESBL-producing E coli. 170 (49%) of 344 approved faecal suspensions had corresponding research faeces aliquots available and were tested (from 11 active donors with a median of eight [IQR five to 26] suspensions per donor). No multidrug-resistant organisms were detected in the 170 approved faecal suspensions (one-sided 95% CI 0 to 1.7). cgMLST revealed that all multidrug-resistant organisms were genetically different.Interpretation Healthy faeces donors can become colonised with multidrug-resistant organisms during donation activities. Our screening protocol did not result in approval of multidrug-resistant organism-positive faecal suspensions for microbiota transplantation. Copyright (C) 2020 Elsevier Ltd. All rights reserved.
- Published
- 2021
- Full Text
- View/download PDF